The FDA has uncovered widespread safety problems in the 44 inspections of high-risk compounding pharmacies conducted so far this year, including lax contamination prevention, a review of inspection reports found. The FDA has asked Congress for greater authority to regulate compounding pharmacies. Meanwhile, the International Academy of Compounding Pharmacists is working with 27 state pharmacy boards to update rules governing compounders, says IACP CEO David Miller.

Full Story:

Related Summaries